Rio Tinto Invest $2 Billion to Modernize Canadian Aluminium Smelter

Rio Tinto’s US$2 billion project to modernise its Kitimat smelter in British Columbia, Canada, will be submitted for Board approval following the decision by the British Columbia Utilities Commission (BCUC) to accept the 2007 Energy Purchase Agreement (2007 EPA) between Rio Tinto Alcan and BC Hydro.

This is the last of three conditions necessary to be met for the project to go ahead. The other two key conditions were the resolution of a long-term labour agreement to ensure stability during the planning, the construction and the start-up of the Modernisation Project (achieved May 2007), and assurances on environmental permitting issues (achieved late December 2007)

Jacynthe Côté, Rio Tinto Alcan Primary Metal President, said: “We are very pleased with today’s BCUC decision to accept the new power agreement between Rio Tinto Alcan and BC Hydro. Final approval of the project will allow us to stay on target to deliver first metal by 2012 and reduce greenhouse gas emissions by half a million tonnes per year.”

The new power agreement provides that the Kitimat smelter’s electricity needs have priority over any other power sales. This will allow Rio Tinto Alcan to adjust its power sales to BC Hydro depending on the final configuration and power requirements of the modernised smelter.

Once approved, the modernisation of Rio Tinto Alcan’s Kitimat smelter would increase Rio Tinto’s annual global primary aluminium production capacity by more than three per cent. This will make Kitimat not only one of Rio Tinto’s largest wholly-owned smelters, but also one of the three largest in North America. Kitimat’s aluminium production capacity would increase by 125,000 tonnes using clean and renewable hydroelectric power from the Rio Tinto Alcan-owned Kemano power station.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.